UBS Group
FEED

UBS Group’s ENvue Medical Inc FEED Stock Holding History

UBS Group’s Portfolio FEED Stock Details FEED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$57 Sell
24
-36
-60% -$78 ﹤0.01% 10190
2025
Q4 		$139 Buy
60
+25
+71% +$118 ﹤0.01% 10151
2025
Q3 		$198 Sell
35
-1,335
-97% -$10K ﹤0.01% 9817
2025
Q2 		$12.7K Buy
1,370
+854
+166% +$25.5K ﹤0.01% 8727
2025
Q1 		$17.6K Buy
516
+141
+38% +$6.47K ﹤0.01% 8314
2024
Q4 		$24.3K Buy
375
+361
+2,579% +$24.4K ﹤0.01% 7751
2024
Q3 		$910 Buy
+14
New +$1.02K ﹤0.01% 8781
2024
Q2 		– Hold
0
– – – 9268
2024
Q1 		– Sell
-32
Closed -$4.07K – 9789
2023
Q4 		$4.07K Sell
32
-49
-60% -$6.01K ﹤0.01% 7905
2023
Q3 		$17.5K Buy
+81
New +$24.1K ﹤0.01% 6878
2023
Q2 		– Sell
-33
Closed -$12.6K – 9394
2023
Q1 		$12.6K Buy
33
+29
+725% +$15.6K ﹤0.01% 7436
2022
Q4 		$2.31K Sell
4
-9
-69% -$7.41K ﹤0.01% 9699
2022
Q3 		$13K Buy
+13
New +$17K ﹤0.01% 8050
2022
Q2 		– Sell
-2
Closed -$4K – 10703
2022
Q1 		$4K Sell
2
-2
-50% -$3.77K ﹤0.01% 9303
2021
Q4 		$8K Buy
+4
New +$11.9K ﹤0.01% 9044
2021
Q3 		– Sell
-12
Closed -$22K – 9879
2021
Q2 		$22K Sell
12
-13
-52% -$26.3K ﹤0.01% 7237
2021
Q1 		$56K Buy
25
+20
+400% +$51.2K ﹤0.01% 6429
2020
Q4 		$8K Buy
+5
New +$8.17K ﹤0.01% 7628
2020
Q2 		– Sell
-1
Closed -$5K – 8207
2020
Q1 		$5K Buy
+1
New +$5.86K ﹤0.01% 7305
2019
Q4 		– Hold
0
– – – 7963
2019
Q3 		– Hold
0
– -$1K – 8155
2019
Q2 		– Hold
0
– – – 7724
2019
Q1 		– Sell
-2
Closed -$16K – 8001
2018
Q4 		$16K Hold
2
– – ﹤0.01% 6945
2018
Q3 		$20K Buy
2
+1
+100% +$10.1K ﹤0.01% 6796
2018
Q2 		$12K Hold
1
– – ﹤0.01% 7036
2018
Q1 		$15K Hold
1
– – ﹤0.01% 6618
2017
Q4 		$10K Buy
+1
New +$10K ﹤0.01% 7026

Other funds holding FEED

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.67B AUM 28.26% 1-Year Est. Return
PCM
Poehling Capital Management Madison, Wisconsin $466M AUM 24.17% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

UBS Group's FEED Position: Q1 2026 in Review

UBS Group reduced its ENvue Medical Inc (FEED) stake by 60% in Q1 2026, selling an estimated $78 and leaving 24 shares worth $57. The position accounts for ﹤0.01% of the portfolio, ranked #10190.

UBS Group first reported a position in FEED in Q4 2017 and has held it in 23 quarters since. The position peaked at $56K in Q1 2021. 13 funds tracked by Wall St. Rank hold FEED as of Q1 2026.

  • UBS Group held 24 shares of ENvue Medical Inc worth $57 as of Q1 2026.
  • UBS Group sold 36 ENvue Medical Inc shares in Q1 2026, an estimated $78.
  • ENvue Medical Inc made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #10190 holding.
  • UBS Group first reported a position in ENvue Medical Inc in Q4 2017 and has held it in 23 quarters since.
  • UBS Group's ENvue Medical Inc position peaked at $56K in Q1 2021.
  • 13 funds tracked by Wall St. Rank held ENvue Medical Inc as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.